(R)-4-Methyloxazolidin-2-one → methyl (R)-3-methyl-4-(4-methyl-2-oxooxazolidin-3-yl)benzoate

HRID 1804029

反応式

HRID 1804029 の反応式
Br[C:2]1[CH:11]=[CH:10][C:5]([C:6]([O:8][CH3:9])=[O:7])=[CH:4][C:3]=1[CH3:12].[CH3:13][C@@H:14]1[CH2:18][O:17][C:16](=[O:19])[NH:15]1>>[CH3:12][C:3]1[CH:4]=[C:5]([CH:10]=[CH:11][C:2]=1[N:15]1[C@H:14]([CH3:13])[CH2:18][O:17][C:16]1=[O:19])[C:6]([O:8][CH3:9])=[O:7]

参加物

3

実験手順

By reaction and treatment in the same manner as in Preparation Example 12 and using methyl 4-bromo-3-methylbenzoate (1.1 g) and (R)-4-methyloxazolidin-2-one (607 mg) described in Preparation Example 25, the title compound (1.2 g) was obtained.

後処理

  1. customBy reaction and treatment in the same manner
  2. customas in Preparation Example 12
  3. customdescribed in Preparation Example 25

出典と根拠

ORDレコード
ord-2633152adc6e4e22b3eb0d9ed530f9c3
出典データセット
uspto-grants-2013_01
特許番号
US08354401B2

関連ノート

読み込み中…